✦ LIBER ✦

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

Book ID: 120979546
Publisher: Massachusetts Medical Society
Year: 2013
Tongue: English
Weight: 621 KB
Volume: 369
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa1306638

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dabigatran Versus Warfarin in the Treatm

Dabigatran Versus Warfarin in the Treatment of Acute Venous Thromboembolism

✍ S. Schulman; C. Kearon; A.K. Kakkar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Dabigatran versus Warfarin in the Treatm

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

✍ Schulman, Sam; Kearon, Clive; Kakkar, Ajay K.; Mismetti, Patrick; Schellong, Seb 📂 Article 📅 2009 🏛 Massachusetts Medical Society 🌐 English ⚖ 344 KB

Indirect comparison of dabigatran, rivar

Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism

✍ Mantha, Simon; Ansell, Jack 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 294 KB

Direct Thrombin Inhibitors for the Treat

Direct Thrombin Inhibitors for the Treatment of Venous Thromboembolism: Analysis of the Dabigatran versus Warfarin Clinical Trial

✍ Timothy K. Liem; Thomas G. DeLoughery 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 479 KB

Dalteparin versus Warfarin for the Preve

Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients

✍ Dranitsaris, George; Vincent, Mark; Crowther, Mark 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 132 KB

Long-term Anticoagulation for Venous Thr

Long-term Anticoagulation for Venous Thromboembolism: Duration of Treatment and Management of Warfarin Therapy

✍ Kearon, Clive 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 231 KB